adalimumab

English

Etymology

From ada- (of unknown origin) +‎ -lim- (“immunomodulating”) +‎ -umab (“human monoclonal antibody”).

Pronunciation

• (General American) IPA^(key): /ˌeɪ.dəˈlɪm.jəˌmæb/

Noun

adalimumab (uncountable)

1. (pharmacology) An immunosuppressive drug (trademark Humira) that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis). It acts by binding to and blocking the activity of tumor necrosis factor.

Translations

monoclonal antibody

• Finnish: adalimumabi

References

• “adalimumab”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.